AYALA PHARMACEUTICALS INC (AYLA)

US05465V1089 - Common Stock

0.5036  +0.03 (+5.84%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.73M3.51M3.71M2.33M0.00
Cost Of Goods
1.64M3.51M3.71M1.29M0.00
Gross Profit
90.00K0.000.001.05M0.00
Operating Expenses
37.63M39.22M29.78M18.76M9.04M
Research and Development
27.81M29.94M22.41M14.42M5.74M
Selling, General, and Administrative Expenses
9.83M9.28M7.37M4.34M3.29M
Operating Income
-37.54M-39.22M-29.78M-17.71M-9.04M
Interest Income/Expense
-224.00K-260.00K60.00K230.00K450.00K
Income Before Taxes
-37.77M-39.48M-29.72M-17.49M-8.59M
Income Tax
708.00K776.00K430.00K310.00K290.00K
Net Income
-38.47M-40.25M-30.15M-17.79M-8.87M
EBITDA
-37.39M-39.05M-29.60M-17.56M-8.99M
 
Per Share Data
EPS Diluted Total Ops
-2.51-2.80-3.06-1.76-0.88
Non GAAP EPS
-2.52-2.83-3.38N/AN/A
 
Statistics
Gross Profit Margin
5.19%N/AN/A45.06%N/A
Profit Margin
-2220.08%-1148.15%-812.67%-763.52%N/A
Operating Profit Margin
-2166.30%-1118.60%-802.70%-760.09%N/A

All data in USD

Charts